Abstract
Among the three major causes of death in developed countries, namely, cardiovascular diseases including heart attack, stroke, and all forms of cancer, the first two are associated with hypertension. Because of the important health impact, many antihypertensive agents have been introduced in the last 50 years. In this review, we shall focus our attention on the following groups: (1) renin inhibitors, (2) calcium channel blockers, (3) α- and β-adrenergic blockers, and (4) angiotensin converting enzyme (ACE) inhibitors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
F. Gross: Am. J. Cardiol., 34, 471–475 (1974).
G. Gross. In: Handbuch der experimentellen Pharmakologie XXXIX, Chapter I.Antihypertensive Drugs. F. Gross (ed.). Springer Verlag, Berlin, pp. 1–11 (1977).
W.J. Greenlee and P.K.S. Siegl. In: Annual Reports in Medicinal Chemistry, Chapter 7, J.A. Bristol (ed.): Angiotensin/renin modulators. Academic Press, Inc. New York 26, 63–72 (1991).
W.J. Greenlee and P.K.S. Siegl. In: Annual Reports in Medicinal Chemistry, Chapter 7, J.A. Bristol (ed.): Angiotensin/renin modulators. Academic Press, Inc. New York 27, 59–68 (1992).
W.J. Greenlee: Med. Res. Rev. 10, 173–236 (1990).
H.D. Kleinert, W.R. Baker and H.H. Stein: Adv. Pharmacol. 22, 207–250 (1991).
R.A. Buchholz, B.A. Lefker and M.A. Ravikiron. In: Annual Reports in Medicinal Chemistry. Chapter 8. Hypertension Therapy, what next? J.A. Bristol (ed.). Academic Press, Inc., New York 28, 69–78 (1993).
D.J. Triggle. In: Calcium in Drug Action. Chapter 6. The chemistry of calcium channel agonists and antagonists. P.F. Baker (ed.). Springer Verlag, Berlin, pp. 115–199 (1988).
L.H. Opie. In: International Encyclopedia of Pharmacology and Therapeutics. Chapter 5. Calcium ions drug action and the heart — with special reference to calcium channel blockers (calcium antagonist dugs). M.A. Denborough (ed.). Pergamon Press, New York, pp. 103–125 (1987).
E.J. Lien, H. Gao, and F. Wang: Med. Chem. Res. 1, 173–184 (1991).
E.J. Lien: Prog. Drug Res. 40, 163–189 (1993).
J.E. Arrowsmith, S.F. Campbell, P.E. Cross et al.: J. Med. Chem. 29, 1696–1702 (1986).
R.A. Burges, D.G. Gardiner, M. Gwilt, et al.: J. Cardiovascul. Pharmacol. 9, 110–119 (1988).
A.P. Beresford, D. McGibney, M.J. Humphrey, et al.: Xenobiotica 18, 245–254 (1988).
G.P. Reams, A. Lau, A. Hamory and J.H. Bauer: Am. J. Kidney Dis. 10, 446–451 (1987).
J. Webster, O.J. Robb, T.A. Jeffers et al.: Br. J. Clin. Pharmacol. 24, 713–719 (1987).
J.K. Faulkner, D. McGibney, L.F. Chasseaud et al.: Br. J. Clin. Pharmacol. 22, 21–25 (1986).
D.B. Zurich, Physician’s Desk Reference, 47 ed Medical Economics Co. Inc., Montvale, N.J., pp.1836–1838 (1993).
S. Vogel, R. Crampton and N. Sperelakis: J. Pharmacol. Exp. Ther. 210, 378–385 (1979).
C. Labrid, A. Grosset, G. Dureng et al.: J. Pharmacol. Exp. Ther. 211, 546–554 (1979).
G.R. Hasegewa: Clin. Pham. 7, 97–108 (1988).
F.P. Zeller and S.A. Spinier: Drug Intell. Clinic. Pharm. 21, 487–492 (1987).
P.W. Pflugfelder, D.P. Humen, P.A. O’Brien et al.: Am. J. Cardiol. 59, 1283–1288 (1987).
J.O. Parker and B. Farrell: Am. J. Cardiol. 58, 449–452 (1986).
R. DiBianco, J. Alpert, R.J. Katz et al.: Am. J. Cardiol. 53, 35–41 (1984).
G. Forche, H. Kopera and H.J. Marsoner: hit. J. Clin. Pharmacol. Ther. Toxicol. 21, 234–240 (1983).
M.A. Duffy, Physicians’ Desk Reference, 46 ed. Medical Economics Data, Montvale, pp.1383–1385 (1992).
B. Edgar, K.J. Hoffman, R. Lundborg et al.: Drugs 29 (suppl. 2), 9–15 (1985).
O. Ronn, B. Bengtsson, B. Edgar and S. Raner: Drugs 29 (suppl. 2), 16–25 (1985).
B. Ljung: Drugs 29 (suppl. 2), 46–58 (1985).
B. Edgar, C.G. Regardh, R. Lundborg et al.: Biopharm. Drug Dispos. 8, 235–248 (1987).
H.E. Sluiter (on behalf of the Dutch Multicentre Study Group): Drugs 34 (suppl. 3), 97–106 (1987).
M.A. Duffy, Physicians’ Desk Reference. 46 ed. Medical Economics Inc. Montvale, pp.1526–1528 (1992).
F.L. Tse and J.M. Jaffe: Eur. J. Clin. Pharmacol. 32, 361–365 (1987).
K. Simonsen and C.D. Sundstedt: Am. J. Med. 86, 91–93 (1989).
C.D. Sundstedt, P.C. Rueegg, A. Keller and R. Waite: Am. J. Med. 86, 98–102 (1988).
H.F. Schran, J.M. Jaffe and L.M. Gonasun: Am. J. Med. 84 (suppl 3B), 80–89 (1988).
L.R. Krusell, L.T. Jespersen, A. Schmit et al.: Hypertension 10, 577–581 (1987).
Anony: New DynaCirc® (isradipine), Pharmacy Fact Sheet, Sandoz Pharm. Co. East Hanover, NJ (1991).
T. Takenaka and J. Handa: Int. J. Clin. Pharmacol. Biopharm. 17, 1–11 (1979).
T. Seki and T. Takenaka: Int. J. Pharmacol. 15,267–274 (1977).
T. Takenaka, S. Usuda, T. Nomura, H. Maeno and T. Sado: Arzneim.-forsch. 26, 2172–2178 (1976).
S. Higuchi and Y. Chiobara: Xenobiotica 10, 447–454 (1980).
S. Higuchi, H. Sasaki and T. Seki: Xenobiotica 10, 897–903 (1980).
Anonymous: Cardene® (nicardipine hydrochloride) capsules, Package insert, Syntex Lab., Inc. Palo Alto (1988).
K. Satoh, T. Yanagisawa and N. Taira: Clin. Exp. Pharmacol. 7, 249–262 (1980).
K.A. Conrad, T.C. Fagan, R Mayshar, T.P. Davis and D.G. Johnson: Clin. Pharmacol. Ther. 42, 113–118 (1987).
E.M. Sorkin and S.P. Clissold: Drugs 33, 296–345 (1987).
S. Kazda, B. Garthoff, H.P. Krause and K. Schlossmann: Arzneim.-Forsch. 32, 331–338 (1982).
R. Towart, E. Wehinger, H. Meyer and S. Kazda: Arzneim.-Forsch. 32, 338–346 (1982).
S. Kazda: Neurochirug. 28 (suppl. 1), 70–73 (1985).
K.-D. Rämsch, G. Ahr, D. Tettenborn and L.M. Auer: Neurochirug. 28 (suppl. 1), 74–83 (1985).
G.S. Allen, H.S. Ahn, T.J. Preziosi et al.: N. Engl. J. Med. 308, 619–624 (1983).
Anonymous: Nimotop® (nimodipine/Miles) capsules, Package insert, Miles Inc., West Haven (1989).
Anonymous: Am. Pharm. NS 29, 58 (1989).
E.J. Lien: US New Drug Digest 1980–1986, Aurora Publishers, Inc., Nashville (1987).
R. Barnhart: Physicians’ Desk Reference, 45 ed. Medical Economics Co. Inc., Oradell, N.J., pp.2074–2076; 572–574 (1991).
H. Bourgeois: Ophtalmologie 4, 323–325 (1990).
M.T. Dorigo, O. Cerin, G. Fracasso and R. Altafini: Int. J. Clin. Pharmacol. Res. 10, 163–166 (1990).
R.N. Winreb, D.R. Caldwell, S.M. Goode et al.: Am. J. Ophthalmol. 110, 189–192 (1990).
S.G. Chrysant, C. Chrysant, I.S. Bal et al.: Hemodynamic Aspects Chest 96, 499–504 (1989).
M.E. Davidov, N. Glazer, G. Wollam et al.: Am. J. Hypertens. 1, 206S - 210S (1988).
W.J. Mroczek, J.F. Burns, L.B. Hogan et al.: Am. J. Cardiol. 61, 807–811 (1988).
S. Morita, Y. Trie, S. Sakuragi, H. Kohri and H. Nishino: Folia Pharmacol. Japan 73, 229–237 (1977).
S. Morita, M. linuma, M. Kido, s. Sakuragi, H. Kohri and N. Nishino: Arzneim.-Forsch. 27, 2380–2383 (1977).
W.H. Fennell, J.A. Fanner, J.B. Young et al.: Clin. Res. 28 (5), 817 (1981).
P.J. Schmitz, G.A. Walker, W.M. Barker and R.W. Stoll: Clin. Res. 29 (2), 23A (1981).
A. Tarkiainen, K. Saraste, T. Seppala: Eur. J. Clin. Pharmacol. 19, 239–244 (1981).
L. Alcocer, J. Aspe, E. Arce and J. Vieyra: Curr. Ther. Res. 31, 67–73 (1982).
E.R. Barnhart, Physicians’ Desk Reference 44 ed. Medical Economics, Co. Inc., Oradell, N.J., pp.510–512 (1990).
R. J. Gorczynski, J.E. Shaffer and R.J. Lee: J. Cardiovasc. Pharmacol. 5, 668–677 (1983).
A. Yacobi, R. Kartzinee, C.M. Lai and C.Y. Sum: J. Pharm. Sci. 72, 710–711 (1983).
R.C. Byrd, R.J. Sung, J. Mark et al.: Clin. Res. 31, 172A (1983).
D. Dickerson, M. Paulos, J. Klein and A. Yacobi: Clin. Res. 31, 179A (1983).
E.R. Barnhart, Physicians’s Desk Reference, 42 ed., Medical Economics Co. Inc., Oradell, N.J., pp.914–916 (1988).
O. Mayer, V. Cepelâk, J. Vitous and J. Potmesl: Int. J. Clin. Pharmacol. Ther. Toxic. 18, 113–120 (1980).
B. de Galleani: Ophthalmologie 3, 220–222 (1989).
C.L. Le Jeunne, F.C. Hugues and J.L. Dufier: J. Clin. Pharmacol. 29, 97–101 (1989).
P.E. Battershill and E.M. Sorkin: Drugs 36, 601–615 (1988).
G.K. Krieglstein, G.D. Novak, E. Voepel et al.: Br. J. Ophthalmol. 71, 250–253 (1987).
O. Mueller and H.R. Knobel: Klin. Monatsbl. Augenheilkd. 188, 62–63 (1986).
K.B. Mills and G. Wright: Br. J. Ophthalmol. 70, 39–42 (1986).
D.A. Hussar: Am. Pharm. NS 31, 54–84 (1991).
E.R. Barnhart: Physicians’s Desk Reference for Ophthalmology, 19 ed., Medical Economics Co. Inc., Oradell, N.J., pp.258–260 (1991).
V.G. Härtfelder, H. Lessenich and K. Schmitt: Arzneim.-Forsch. 22, 930–932 (1972).
V.J. Kaiser, G. Härtfelder, E. Lindner and B. Schölkens: Arzneim.-Forsch. 30, 420–427 (1980).
H.W. Jun, S.L. Hayes, J.J. Vallner, I.L. Honigberg, A.E. Rojos and J.T. Stewart: J. Clin. Pharmacol. 19, 415–423 (1979).
S.D. Sharma, A.D. Mehra and B.J. Vakil: Curr. Ther. Res. 27, 576–583 (1980).
P.L. Sharma and R.P. Sapru: Int. J. Clin. Pharmacol. 16, 83–85 (1978).
E.R. Von Leitner and G. Biamino: Eur. J. Cardiol. 12, 121–128 (1980).
W.S. Hillis, A.C. Tweddel, R.G. Murray and T.D.V. Lawrie: Arzneim.-Forsch. 30, 1595–1599 (1980).
Anonymous: Tablets Levatol, penbutolol sulfate, Package insert, Reed & Carnrick, Piscataway, N.J. (1988).
H.L. Elliott, P.A. Meredith, D.J. Sumner et al.: Br. J. Clin. Pharmacol. 13, 699–703 (1982).
H. Shionoiri, G. Yasuda, H. Yoshimura et al.: J. Cardiovasc. Pharmacol. 10, 90–95 (1987).
P. Hjortdahl, H. von Krogh, L. Daae et al.: Acta. Med. Scand. 221, 427–434 (1987).
P.W. de Leeuw, P.N. van Es, R. de Bos et al.: Hypertension 9 (111), 210–212 (1987).
K. Hayduk and H.T. Schneider: Am. J. Cardiol. 59, 95G - 98G (1987).
D.T. Nash, G. Schonfeld, R.L. Reeves et al.: Am. J. Cardiol. 59, 87G - 90G (1987).
H.L. Elliott, P.A. Meredith and J.L. Reid: Am. J. Cardiol. 59, 78G - 81G (1987).
Anonymous: Am. Pharm. NS 31, 12 (1991).
J.J. Kyncl, R.E. Hollinger, K.O. Oheim and M. Winn: Pharmacologist 22, 272 (1980).
H.F. Oates: N. Zeal. Med. J. 94, 67 (1981).
S. Mizogami and M. Hanazuka: Jap. J. Pharmacol. (suppl.), 174P (1982).
F.L. Fort, S. Tekeli, K. Majors et al.: Drug Chem. Toxicol. 7, 435–449 (1984).
J.H. Mersey and U. Elkayam: Clin. Res. 32, 688A (1984).
A.J. Dietz, Jr., E. Magarian, D. Freeman and J. Carlson: J. Clin. Pharmacol. 24, 416 (1984).
Anonymous: Hytrin® (terazosin hydrochloride tablets) package insert, Abbott Health Care Products, Inc., North Chicago, Ill. (1987).
A. Salvetti: Drugs 6, 800–828 (1990).
J. G. Kelly and K. O’Malley: Clin. Pharmacokinetics 19, 177–196 (1990).
M.H. Winberger, H.R. Black, K.C. Lasseter, et al.: Clin. Phannacol. Ther. 47, 608–617 (1990).
G. Kaiser, R. Ackermann, S. Brechbuehler and W. Dieterle: Biopharm. Drug Dispos. 10, 365–367 (1989).
J. Insel, S.M. Mirvis, M.J. Boland et al.: Clin. Pharmacol. Ther. 45, 312–320 (1989).
E. Valvo, P. Casagrande, V. Bedona et al.: J. Hypertens. 8, 991–995 (1990).
M. Bellet, J.J. Whalen, F. Bodin et al.: J. Hypertens. 4 (suppl. 8), S43–48 (1990).
M.H. Winberger, H.R. Black, K.C. Lasseter et al.: Clin. Pharmacol. Ther. 47, 608–617 (1990).
D.B. Eurich: Physicians’ Desk Reference, 47 ed., Medical Economics Co. Inc., Montvale, pp. 902–904 (1993).
G. Waldemar, H. Ibsen, S. Strandaard et al.: Am. J. Hypertens. 3, 464 170 (1990).
S.M. Singhvi, K.L. Duchin, R.A. Morrison et al.: Br. J. Clin. Pharmacol. 25, 9–15 (1988).
K.L. Duchin, A.P. Waclawski, J.I. Tu et al.: J. Clin. Pharmacol. 31, 58–64 (1991).
R.J. Anderson, T.M. Nolen, P. Wolfson et al.: Hypertens. 17, 636–642 (1991).
P.A. Sullivan, M. Dineen, J. Cervenka and D.T. O’Connor: Am. J. Hypertens. 1, 280S - 283S (1988).
M.A. Duffy, Physicians’ Desk Reference, 46 ed., Medical Economics data, Montvale, pp.1406–1409 (1992).
D.B. Brunner, G. Desponds, J. Biollaz et al.: Br. J. Clin. Pharmacol. 11, 461–467 (1981).
E.H. Ulm, M. Hichens and H.J. Gomez: Br. J. Clin. Pharmacol. 14, 357–362 (1982).
M.S. Kochar, G. Bolek, J.H. Kalbfleisch and P. Olzinski: J. Clin. Pharmacol. 27, 373–377 (1987).
K. Bolzano, J. Arriaga, R. Bernal et al.: J. Cardiovas. Pharmacol. 9 (suppl. 3), S43–47 (1987).
C. Mörlin, H. Baglivo, J.K. Boeijinga et al.: J. Cardiovas. Pharmacol. 9 (suppl. 3), S48–52 (1987).
G.J. Frank, K. E. Kapp and R.W. McLain: Angiology 40, 405–415 (1989).
D. Maclean: Angiology 40, 370–381 (1989).
A.J. Sedman and E. Posvar: Angiology 40, 360–369 (1986).
S.C. Olson, A.M. Horvath, B.M. Micaniewicz et al.: Angiology 40, 351–359 (1989).
J.J. Ferry, A.M. Horvath, M. Easton-Talyor et al.: J. Chromatog. 421, 187–191 (1987).
P. Holt, J. Najm and E. Sowton: Eur. J. Clin. Pharmacol. 31, 9–14 (1986).
R.A. Becker and B. Schoelkens: Am. J. Cardiol. 59, 3D - 11D (1987).
K. Felder and P.U. Witte: Arzneim.-Forsch. 34, 1452–1454 (1984).
H.G. Eckert, M. J. Badian and D. Gantz: Arzneim.-Forsch. 34, 1435–1447 (1984).
P.W. de Leeuw and W.H. Birkenhaeger: Am. J. Cardiol. 59, 79D - 82D (1987).
M.A. Duff, Physicians’ Desk Reference, 46 ed., Medical Economics Data, Montvale, pp.1086–1089 (1992).
M. Aurell, K. Delin, H. Herlitz et al.: An. J. Cardiol. 59, 65D - 69D (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Birkhäuser Verlag, Basel (Switzerland)
About this chapter
Cite this chapter
Lien, E.J., Gao, H., Lien, L.L. (1994). In search of ideal antihypertensive drugs: Progress in five decades. In: Jucker, E. (eds) Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques, vol 43. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7156-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7156-3_3
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7158-7
Online ISBN: 978-3-0348-7156-3
eBook Packages: Springer Book Archive